People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
The FDA plans to begin requiring one clinical study, instead of the standard two, for medical products before consideration ...
Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans ...
Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to ...
MELBOURNE, Australia, December 5, 2025 (EZ Newswire) -- iNGENū CRO, a global contract research organization, has set out the ...
Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback